| Dr Melissa Anne Papp, MD | |
|
1401 25th St S, Great Falls, MT 59405-5183 | |
| (406) 731-8888 | |
| (406) 731-8876 |
| Full Name | Dr Melissa Anne Papp |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 14 Years |
| Location | 1401 25th St S, Great Falls, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700198983 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 67009 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Benefis Hospitals Inc | Great falls, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benefis Hospitals Inc | 1153235296 | 279 |
News Archive
Howorth Air Technology, known globally for its Exflow ultra clean ventilation canopy, has added a relocatable permanent or semi-permanent "isolation room" to its portfolio of products - BioSphere.
Patients who are unrealistically optimistic about their personal health risks are more likely to take preventive action when confronted with news that is worse than expected, while unrealistic pessimists are less likely to change their behavior after receiving feedback that is better than expected, according to researchers at the University of California, Riverside and Grand Valley State University in Allendale, Mich.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
› Verified 4 days ago
| Entity Name | Benefis Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780968974 PECOS PAC ID: 1153235296 Enrollment ID: O20100629000044 |
News Archive
Howorth Air Technology, known globally for its Exflow ultra clean ventilation canopy, has added a relocatable permanent or semi-permanent "isolation room" to its portfolio of products - BioSphere.
Patients who are unrealistically optimistic about their personal health risks are more likely to take preventive action when confronted with news that is worse than expected, while unrealistic pessimists are less likely to change their behavior after receiving feedback that is better than expected, according to researchers at the University of California, Riverside and Grand Valley State University in Allendale, Mich.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Anne Papp, MD 1401 25th St S, Great Falls, MT 59405-5183 Ph: (406) 731-8888 | Dr Melissa Anne Papp, MD 1401 25th St S, Great Falls, MT 59405-5183 Ph: (406) 731-8888 |
News Archive
Howorth Air Technology, known globally for its Exflow ultra clean ventilation canopy, has added a relocatable permanent or semi-permanent "isolation room" to its portfolio of products - BioSphere.
Patients who are unrealistically optimistic about their personal health risks are more likely to take preventive action when confronted with news that is worse than expected, while unrealistic pessimists are less likely to change their behavior after receiving feedback that is better than expected, according to researchers at the University of California, Riverside and Grand Valley State University in Allendale, Mich.
Peptimmune, Inc., a privately held biotechnology company, announced the completion of a clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PI-2301 in subjects with Secondary Progressive Multiple Sclerosis (SP-MS). PI-2301 is a novel peptide copolymer for the treatment of multiple sclerosis and other autoimmune diseases.
AmpliPhi BioSciences Corp. (OTC: APHB) ("AmpliPhi"), the leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant bacterial infections, yesterday presented data relating to the use of bacteriophages in the treatment of Pseudomonas aeruginosa (P. aeruginosa) at the 20th Biennial Evergreen International Phage Meeting held in Olympia, Washington, USA. P. aeruginosa is the major cause of lung infections in cystic fibrosis (CF) patients.
Over four times as many patients with a rapidly fatal type of brain cancer, glioblastoma multiforme (GBM), who are treated with the chemotherapy drug temozolomide (TMZ) and radiation therapy, can live for four years after diagnosis, compared to those who receive only radiation treatment, according to updated results of a large, international trial presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
› Verified 4 days ago
Francis J Handwerk, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1400 29th St S, Great Falls, MT 59405 Phone: 406-454-2171 Fax: 406-771-3021 | |
Mr. Jeffery A Palen, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888 | |
Vicki L Chapman, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S, Ste 101, Great Falls, MT 59405 Phone: 406-761-7924 | |
Daren J Braget, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S, Suite 101, Great Falls, MT 59405 Phone: 406-761-7924 Fax: 406-761-7924 | |
Julie L Kuykendall, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8876 | |
Julia C Middleton, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S Ste 101, Great Falls, MT 59405 Phone: 406-761-7924 | |
Sandra L Bailey, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1400 29th St S, Suite 101, Great Falls, MT 59405 Phone: 406-761-7924 Fax: 406-761-7945 |